DOPAMINE NEUROTRANSMISSION AND BRAIN FUNCTIONUNGERSTEDT U; HERRERA MARSCHITZ M; ZETTERSTROEM T et al.1982; PROG. BRAIN RES.; ISSN 0079-6123; NLD; DA. 1982; VOL. 55; PP. 41-49; BIBL. 2 P.Conference Paper

MIF (PRO-LEU-GLY-NH₂): FAILURE TO AFFECT OXOTREMORINE EFFECTS IN MICE AND RATS AS WELL AS FLUPHENAZINE CATALEPSY OR AMPHETAMINE HYPERACTIVITY IN RATSBJOERKMAN S; LEWANDER T; ZETTERSTROEM T et al.1980; J. PHARM. PHARMACOL.; GBR; DA. 1980; VOL. 32; NO 4; PP. 296-297; BIBL. 15 REF.Article

Adenosine agonists can both inhibit and enhance in vivo striatal dopamine releaseZETTERSTROÊM, T; FILLENZ, M.European journal of pharmacology. 1990, Vol 180, Num 1, pp 137-143, issn 0014-2999Article

THE PHARMACOLOGICAL ASSESSMENT OF A NEW, POTENT OXOTREMORINE ANALOGUE IN MICE AND RATSRESUL B; LEWANDER T; RINGDAHL B et al.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 80; NO 2-3; PP. 209-215; BIBL. 28 REF.Article

Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the ratPEI, Q; ZETTERSTROÊM, T; FILLENZ, M et al.Neuroscience. 1990, Vol 35, Num 1, pp 133-138, issn 0306-4522Article

PURINE LEVELS IN THE INTACT RAT BRAIN. STUDIES WITH AN IMPLANTED PERFUSED HOLLOW FIBREZETTERSTROEM T; VERNET L; UNGERSTEDT U et al.1982; NEUROSCI. LETT.; ISSN 0304-3940; NLD; DA. 1982; VOL. 29; NO 2; PP. 111-115; BIBL. 14 REF.Article